Emyria (ASX:EMD)

Mental Health Care • Perth, Western Australia, Australia • 11-20 Employees

Company overview

Headquarters	661 Newcastle St, Leederville, Western Australia 6007, AU
Phone number	+61412614125
Website	emyria.com
NAICS	621112
Employees	11-20
Socials

Key Contact at Emyria (ASX:EMD)

Michael Winlo

Chief Executive Officer And Managing Director

Emyria (ASX:EMD) Email Formats

Emyria (ASX:EMD) uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@emyria.com), used 75% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@emyria.com	75%
{first initial}{last name}	jdoe@emyria.com	25%

About Emyria (ASX:EMD)

Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model: Emyria Care: Deliver evidence-based and emerging therapies for mental health and other unmet needs across multiple sites (Empax Centres). Emyria Data: Robust and ethically-sourced Real-World Data gathered with patients. Emyria Data is used to improve Emyria’s distinct therapy and drug development programs. Emyria Drug Discovery: One of the world's largest libraries of unique MDMA-like compounds developed in partnership with the University of Western Australia for a range of mental health and select neuroscience indications.

Emyria (ASX:EMD) revenue & valuation

Annual revenue	$1,487,964
Revenue per employee	$124,000
Estimated valuation?This valuation is estimated based on industry average for the Mental Health Care industry and current estimated revenues	$4,800,000
Total funding	$6,100,000